Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation

Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation

US Patent 7524495 · Granted Apr 28, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific binding molecules binding to VEGF and Ang22021
Bispecific binding molecules binding to VEGF and Ang22019
Bispecific binding molecules binding to VEGF and ANG22016
Method for treatment of diabetes by a small molecule inhibitor for GRK52016
Quinoline derivatives as AXL kinase inhibitors2015
Inhibitors of her3 activity2015
Pharmaceutically active compounds as Axl inhibitors2015
Quinolinyloxyphenylsulfonamides2014
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal tra2013
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal tra2013
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal tra2013
Human nerve growth factor by recombinant technology2013